These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 16563665)
21. Mechanism of binding of fluoroquinolones to the quinolone resistance-determining region of DNA gyrase: towards an understanding of the molecular basis of quinolone resistance. Madurga S; Sánchez-Céspedes J; Belda I; Vila J; Giralt E Chembiochem; 2008 Sep; 9(13):2081-6. PubMed ID: 18677735 [TBL] [Abstract][Full Text] [Related]
22. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets. Turner AK; Nair S; Wain J J Antimicrob Chemother; 2006 Oct; 58(4):733-40. PubMed ID: 16895934 [TBL] [Abstract][Full Text] [Related]
23. Molecular mechanisms of decreased susceptibility to fluoroquinolones in avian Salmonella serovars and their mutants selected during the determination of mutant prevention concentrations. Kehrenberg C; de Jong A; Friederichs S; Cloeckaert A; Schwarz S J Antimicrob Chemother; 2007 May; 59(5):886-92. PubMed ID: 17369276 [TBL] [Abstract][Full Text] [Related]
24. Analysis of topoisomerase mutations in fluoroquinolone-resistant and -susceptible Campylobacter jejuni strains isolated in Senegal. Kinana AD; Cardinale E; Bahsoun I; Tall F; Sire JM; Garin B; Boye CS; Dromigny JA; Perrier-Gros-Claude JD Int J Antimicrob Agents; 2007 Apr; 29(4):397-401. PubMed ID: 17224260 [TBL] [Abstract][Full Text] [Related]
25. [PCR-restriction fragment length polymorphism assay (PCR-RFLP) as an useful tool for detection of mutation in gyrA gene at 86-THR position associated with fluoroquinolone resistance in Campylobacter jejuni]. Wardak S; Szych J; Cieślik A Med Dosw Mikrobiol; 2005; 57(3):295-301. PubMed ID: 16494206 [TBL] [Abstract][Full Text] [Related]
26. Prevalence and mechanisms of resistance to fluoroquinolones in Helicobacter pylori strains from patients living in Belgium. Bogaerts P; Berhin C; Nizet H; Glupczynski Y Helicobacter; 2006 Oct; 11(5):441-5. PubMed ID: 16961806 [TBL] [Abstract][Full Text] [Related]
27. Spontaneous mutation frequency and emergence of ciprofloxacin resistance in Campylobacter jejuni and Campylobacter coli. Hänninen ML; Hannula M J Antimicrob Chemother; 2007 Dec; 60(6):1251-7. PubMed ID: 17911389 [TBL] [Abstract][Full Text] [Related]
28. In vitro assessment of the further potential for development of fluoroquinolone resistance in Neisseria meningitidis. Shultz TR; White PA; Tapsall JW Antimicrob Agents Chemother; 2005 May; 49(5):1753-60. PubMed ID: 15855492 [TBL] [Abstract][Full Text] [Related]
29. Mutant-prevention concentrations of enrofloxacin for Escherichia coli isolates from chickens. Li Q; Bi X; Diao Y; Deng X Am J Vet Res; 2007 Aug; 68(8):812-5. PubMed ID: 17669019 [TBL] [Abstract][Full Text] [Related]
30. Mutant prevention concentration of ciprofloxacin and enrofloxacin against Escherichia coli, Salmonella Typhimurium and Pseudomonas aeruginosa. Pasquali F; Manfreda G Vet Microbiol; 2007 Jan; 119(2-4):304-10. PubMed ID: 16987619 [TBL] [Abstract][Full Text] [Related]
31. Study of isolation of fluoroquinolone-resistant Ureaplasma urealyticum and identification of mutant sites. Zhang W; Wu Y; Yin W; Yu M Chin Med J (Engl); 2002 Oct; 115(10):1573-5. PubMed ID: 12490114 [TBL] [Abstract][Full Text] [Related]
32. Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients. Kim JM; Kim JS; Kim N; Jung HC; Song IS J Antimicrob Chemother; 2005 Nov; 56(5):965-7. PubMed ID: 16159928 [TBL] [Abstract][Full Text] [Related]
33. [Mutations of gyrA in ciprofloxacin resistant Escherichia coli strains]. Eraç B; Gill A; Amyes SG; Gülay Z Mikrobiyol Bul; 2003; 37(2-3):125-30. PubMed ID: 14593893 [TBL] [Abstract][Full Text] [Related]
34. Molecular basis of quinolone resistance in Escherichia coli from wild birds. Jiménez Gómez PA; García de los Rios JE; Rojas Mendoza A; de Pedro Ramonet P; García Albiach R; Reche Sainz MP Can J Vet Res; 2004 Jul; 68(3):229-31. PubMed ID: 15352551 [TBL] [Abstract][Full Text] [Related]
35. [Investigating the fluoroquinolone molecular resistant mechanism of Stenotrophomonas maltophilia]. Tao CM; Lü XJ; Li P Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):266-9. PubMed ID: 16608091 [TBL] [Abstract][Full Text] [Related]
36. Role of type II topoisomerase mutations and AcrAB efflux pump in fluoroquinolone-resistant clinical isolates of Proteus mirabilis. Saito R; Sato K; Kumita W; Inami N; Nishiyama H; Okamura N; Moriya K; Koike K J Antimicrob Chemother; 2006 Sep; 58(3):673-7. PubMed ID: 16870650 [TBL] [Abstract][Full Text] [Related]
37. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin. Malhotra-Kumar S; Van Heirstraeten L; Lammens C; Chapelle S; Goossens H J Antimicrob Chemother; 2009 May; 63(5):886-94. PubMed ID: 19279051 [TBL] [Abstract][Full Text] [Related]
38. Changes in antimicrobial susceptibility in a population of Salmonella enterica serovar Dublin isolated from cattle in Japan from 1976 to 2005. Akiba M; Nakaoka Y; Kida M; Ishioka Y; Sameshima T; Yoshii N; Nakazawa M; Uchida I; Terakado N J Antimicrob Chemother; 2007 Dec; 60(6):1235-42. PubMed ID: 17956907 [TBL] [Abstract][Full Text] [Related]
39. Mutations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in clinical strains of fluoroquinolone-resistant Shigella in Anhui, China. Hu LF; Li JB; Ye Y; Li X J Microbiol; 2007 Apr; 45(2):168-70. PubMed ID: 17483803 [TBL] [Abstract][Full Text] [Related]
40. Role of efflux pumps and topoisomerase mutations in fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli. Ge B; McDermott PF; White DG; Meng J Antimicrob Agents Chemother; 2005 Aug; 49(8):3347-54. PubMed ID: 16048946 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]